Healthcare Industry News: ALEUTIAN
News Release - October 20, 2011
K2M Announces Official Global Launch of RAVINE(R) Lateral Access System at 2011 Society for Minimally Invasive Spine Surgery Annual MeetingLEESBURG, Va.--(Healthcare Sales & Marketing Network)-- K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the official global launch of the RAVINE® Lateral Access System along with the ALEUTIAN® Lateral Interbody System at the 2011 Society for Minimally Invasive Spine Surgery (SMISS) Annual Meeting in Las Vegas.
RAVINE provides a dual flat blade platform for a less invasive muscle splitting transpsoas approach. The system offers rigid fixation to the spine and the versatility of both a third and fourth blade intraoperative option. It represents an innovative design departure from the tubular retractors, while providing tremendous adaptability to both patient anatomy and surgeon technique.
According to Dr. Pierce Nunley, Orthopedic Surgeon at The Spine Institute of Louisiana, “The RAVINE retractor provides an innovative anatomical deployment and retraction that was designed from the outset to be a transpsoas retractor. This decreases the retraction of tissue, while providing the surgeon with secure access to the disc space.”
“Following our initial debut of RAVINE at the 2010 NASS, we conducted global training and infrastructure expansion to execute the global launch,” stated Eric Major, K2M’s President and CEO. “This next generation product reaffirms our commitment to being a pioneer in the global spine market and a leader in the minimally invasive market.”
K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.